How Common Is Pyoderma Gangrenosum and Who Gets It?
At a Glance
Pyoderma gangrenosum is very rare, with about 3–10 new cases per million people each year. It is most often diagnosed in adults, especially women, and more than half of patients may have an associated condition such as inflammatory bowel disease, arthritis, or a blood disorder.
In this answer
3 sections
Pyoderma gangrenosum (PG) is a very rare inflammatory skin condition. Despite its name, it is not a contagious bacterial infection [1]. Research shows that only about 3 to 10 people per million develop it each year [2]. While it can affect anyone at any age, it is most frequently diagnosed in adults—particularly women [3][4].
PG involves abnormal immune system inflammation; some people who develop it also have an associated systemic medical condition (like inflammatory bowel disease or arthritis), while others do not [5]. Because of this, care is often led by a dermatologist, with other specialists joining the team only if your symptoms or medical history point to another illness [3].
Just How Rare is It?
Medical researchers look at how common a disease is in two ways: how many new cases appear each year (incidence) and how many people currently have it (prevalence).
- New cases (Incidence): Worldwide estimates suggest that between 3 and 10 new cases of PG occur per one million people every year [2]. To put that in perspective, in a city of one million people, doctors might only see a handful of new cases annually.
- Total cases (Prevalence): A large study of patient records in the United States found that about 5.8 out of every 100,000 adults (or roughly 58 per million) are living with the condition at any given time [4].
Because it is so uncommon and can look like ordinary infections or other types of ulcers, PG is notoriously difficult to diagnose and is frequently misdiagnosed [1]. There is no single definitive blood test or biopsy that proves a person has PG; instead, doctors must rely on careful clinical assessment and rule out other mimicking conditions [6].
Age and Sex Patterns
While pyoderma gangrenosum can strike at any age, there are clear patterns in who is most likely to develop it. However, it is important to remember that these are just general trends—not absolute rules. Anyone of any gender or age can be affected [7][8].
- Age: It primarily affects adults. The average age when symptoms first appear is typically in the early 50s, though the highest overall rates are seen in people in their 70s [3][4]. It is extremely rare in children, who account for less than 4% of reported cases [7].
- Sex: Although men and women both get PG, many studies show it is more common in women [4]. In some specialty clinics, up to 75% of patients evaluated for PG were women [3]. (Note that statistics from specialty clinics may overrepresent certain groups compared to the general population).
The Link to Other Health Conditions
More than half of all people diagnosed with PG—between 56% and 67% in various studies—have an associated underlying health condition [5][3]. These conditions may have been known before the PG appeared, found around the time of diagnosis, or may develop later [9].
These estimates often come from overlapping groups of patients at specialized referral centers. The most common associations include:
- Inflammatory Bowel Disease (IBD): Conditions like ulcerative colitis and Crohn’s disease (chronic inflammation of the digestive tract) are the most frequent companions to PG. Studies estimate that between 17% and 41% of people with PG also have IBD [5][3]. IBD is particularly common in younger PG patients (under age 65) [3].
- Inflammatory Arthritis: About 12% to 20% of people with PG have an inflammatory joint disease [5][3]. This refers to autoimmune joint inflammation—with rheumatoid arthritis being the most common type—which is entirely different from common, wear-and-tear osteoarthritis [10].
- Blood and Bone Marrow Disorders: Between 5% and 9% of patients have an associated blood or bone marrow disorder [5][3]. These range from blood cancers to conditions where blood cells do not form properly, such as myelodysplastic syndrome [11][3]. These associations are more common in patients diagnosed with PG at age 65 or older [3].
- Solid Tumors: A smaller percentage of patients (around 6% to 7%) have other forms of solid organ cancer [5][3].
What This Means for Your Care
Because these statistical associations exist, a new PG diagnosis will usually prompt your clinician to review your symptoms and medical history to guide an individualized evaluation [3].
It is important not to panic about the risk of “hidden” illnesses. There is no single universal screening panel or automatic cancer workup required for everyone with PG. Instead, you should simply continue your normal age-appropriate health and cancer screenings and report any new or unusual symptoms to your doctor.
Finally, while managing an associated condition can sometimes help with overall disease control, PG requires its own direct dermatologic treatments and wound care. Healing of the skin is not guaranteed simply by treating another illness, so direct care for your ulcers remains essential.
Common questions in this guide
How rare is pyoderma gangrenosum?
What age and sex are most often affected by pyoderma gangrenosum?
Is pyoderma gangrenosum associated with other medical conditions?
Does everyone with pyoderma gangrenosum need cancer tests?
How is pyoderma gangrenosum diagnosed?
Which doctor usually coordinates care for pyoderma gangrenosum?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Which tests or evaluations are appropriate for me right now, and which routine screenings should I just continue as normal?
- 2.Who will take the lead in coordinating my care and directly treating my skin ulcers?
- 3.If an underlying condition is found, how will we balance the treatment for that with the specific wound care needed for my skin?
- 4.Are there specific new symptoms (like joint swelling or digestive issues) that I should watch out for and report to you?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (11)
- 1
Clinical Mimickers Misdiagnosed as Pyoderma Gangrenosum.
Becker SL, Badawi AH, Thornton C, Ortega-Loayza AG
American journal of clinical dermatology 2025; (26(4)):511-523 doi:10.1007/s40257-025-00941-z.
PMID: 40155526 - 2
Epidemiology of pyoderma gangrenosum: Results from an Italian prospective multicentre study.
Monari P, Moro R, Motolese A, et al.
International wound journal 2018; (15(6)):875-879 doi:10.1111/iwj.12939.
PMID: 29877043 - 3
The Association of Age With Clinical Presentation and Comorbidities of Pyoderma Gangrenosum.
Ashchyan HJ, Butler DC, Nelson CA, et al.
JAMA dermatology 2018; (154(4)):409-413 doi:10.1001/jamadermatol.2017.5978.
PMID: 29450453 - 4
Prevalence estimates for pyoderma gangrenosum in the United States: An age- and sex-adjusted population analysis.
Xu A, Balgobind A, Strunk A, et al.
Journal of the American Academy of Dermatology 2020; (83(2)):425-429 doi:10.1016/j.jaad.2019.08.001.
PMID: 31400451 - 5
Underlying Systemic Diseases in Pyoderma Gangrenosum: A Systematic Review and Meta-Analysis.
Kridin K, Cohen AD, Amber KT
American journal of clinical dermatology 2018; (19(4)):479-487 doi:10.1007/s40257-018-0356-7.
PMID: 29721816 - 6
Comparison of Three Diagnostic Frameworks for Pyoderma Gangrenosum.
Haag C, Hansen T, Hajar T, et al.
The Journal of investigative dermatology 2021; (141(1)):59-63 doi:10.1016/j.jid.2020.04.019.
PMID: 32445742 - 7
Pyoderma gangrenosum with splenic involvement.
AlDossary SJ, AlFawaz TS, AlMutairi AK
International journal of pediatrics & adolescent medicine 2016; (3(2)):78-80 doi:10.1016/j.ijpam.2016.03.007.
PMID: 30805472 - 8
Pyoderma gangrenosum: A clinico-epidemiological study.
Riyaz N, Mary V, Sasidharanpillai S, et al.
Indian journal of dermatology, venereology and leprology 2017; (83(1)):33-39 doi:10.4103/0378-6323.188654.
PMID: 27549869 - 9
Pyoderma gangrenosum and underlying diseases in Japanese patients: A regional long-term study.
Inoue S, Furuta JI, Fujisawa Y, et al.
The Journal of dermatology 2017; (44(11)):1281-1284 doi:10.1111/1346-8138.13937.
PMID: 28635156 - 10
Inflammatory arthritis-associated pyoderma gangrenosum: a systematic review.
Sawka E, Zhou A, Latour E, et al.
Clinical rheumatology 2021; (40(10)):3963-3969 doi:10.1007/s10067-021-05768-7.
PMID: 34002351 - 11
Bullous Pyoderma Gangrenosum With Subungual Involvement Associated With Ulcerative Colitis.
Aktaş Karabay E, Aksu Cerman A, Kıvanc Altunay İ, Yalçın Ö
The American Journal of dermatopathology 2017; (39(6)):476-478 doi:10.1097/DAD.0000000000000801.
PMID: 27893467
This page provides general information about pyoderma gangrenosum prevalence and associated conditions for informational purposes only and does not constitute medical advice. Your dermatologist or clinician can recommend the right evaluation and screening plan for you.
Get notified when new evidence is published on Pyoderma gangrenosum.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.